Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2019-03-28, Stock:PFE, The news for the past five days is as follows:
2019-03-21: NEWS1: Biogen’s Big Bet in Alzheimer’s Disease Is a Bust.NEWS2: Biogen’s Big Bet in Alzheimer’s Disease Is a Bust.NEWS3: Boeing&apos;s Lesson About The Dow.NEWS4: Merck's Keytruda Picks Up Pace in Thriving Anti-PD-L1 Market.NEWS5: Merck's Keytruda Picks Up Pace in Thriving Anti-PD-L1 Market.NEWS6: Merck's Keytruda Picks Up Pace in Thriving Anti-PD-L1 Market.NEWS7: Pfizer buys stake in French gene company in deal worth up to $636M.NEWS8: Health Care Sector Update for 03/21/2019: BIIB, OGEN, NVCN, JNJ, PFE, ABT, MRK, AMGN.NEWS9: Health Care Sector Update for 03/21/2019: BIIB, OGEN, NVCN, JNJ, PFE, ABT, MRK, AMGN.NEWS10: Novo Nordisk A/S (NVO) Ex-Dividend Date Scheduled for March 22, 2019.NEWS11: Novo Nordisk A/S (NVO) Ex-Dividend Date Scheduled for March 22, 2019.NEWS12: 5 of the Best Dow Jones Stocks to Buy for Solid Dividends.NEWS13: 5 of the Best Dow Jones Stocks to Buy for Solid Dividends.
2019-03-22: NEWS1: Final Trades: Verizon, XPO, Pfizer, Alphabet and BB&T.NEWS2: Aerie (AERI) Starts Phase II Study on Eye Candidate in Japan.NEWS3: Aerie (AERI) Starts Phase II Study on Eye Candidate in Japan.NEWS4: Dow 30 Stock Roundup: AAPL Refreshes Product Lineup, BA Wins $327M Navy Order.NEWS5: Dow 30 Stock Roundup: AAPL Refreshes Product Lineup, BA Wins $327M Navy Order.
2019-03-25: NEWS1: Were Hedge Funds Right About Pfizer Inc. (PFE)?.NEWS2: Ascendis Pivotal Growth Hormone Deficiency Study Data Positive.NEWS3: Ascendis Pivotal Growth Hormone Deficiency Study Data Positive.NEWS4: After Hours Most Active for Mar 25, 2019 :  XOG, HST, CMCSA, S, CELG, COTY, QQQ, MAT, TGNA, PFE, NEM, UAL.NEWS5: After Hours Most Active for Mar 25, 2019 :  XOG, HST, CMCSA, S, CELG, COTY, QQQ, MAT, TGNA, PFE, NEM, UAL.NEWS6: Ascendis Pivotal Growth Hormone Deficiency Study Data Positive.NEWS7: SPYG, PFE, CRM, MDT: Large Inflows Detected at ETF.NEWS8: SPYG, PFE, CRM, MDT: Large Inflows Detected at ETF.NEWS9: S&P 500 Q4 2018 Buybacks Set 4th Consecutive Quarterly Record at $223 Billion; 2018 Sets Record $806 Billion.NEWS10: Health Care Sector Update for 03/25/2019: NK, MDWD, AIMT, JNJ, PFE, ABT, MRK, AMGN.NEWS11: Health Care Sector Update for 03/25/2019: NK, MDWD, AIMT, JNJ, PFE, ABT, MRK, AMGN.
2019-03-26: NEWS1: Amid talk of buyout, Peninsula biotech zeroes in on its blood-thinner antidote.NEWS2: AbbVie's Psoriasis Drug Skyrizi Gets First Approval in Japan.NEWS3: AbbVie's Psoriasis Drug Skyrizi Gets First Approval in Japan.NEWS4: Cyclacel Drops After Study Supporting Cancer Drug's Mechanism Of Action.NEWS5: AbbVie's Psoriasis Drug Skyrizi Gets First Approval in Japan.
2019-03-27: NEWS1: Pfizer (PFE) Dips More Than Broader Markets: What You Should Know.NEWS2: Calithera (CALA) Initiates Phase I/II Study of Telaglenastat.NEWS3: After Hours Most Active for Mar 27, 2019 :  TAL, V, BILI, COTY, MRK, BZUN, IRBT, PFE, RXN, QQQ, MSFT, MCHI.NEWS4: After Hours Most Active for Mar 27, 2019 :  TAL, V, BILI, COTY, MRK, BZUN, IRBT, PFE, RXN, QQQ, MSFT, MCHI.NEWS5: 6 Stocks With High Dividend Yields.NEWS6: 6 Gene Therapy M&A Targets On The Radar.NEWS7: Pfizer Stock Will Gain Because Its Pipeline Has Promise, Analyst Says.

Answer: Rise